British HIV Association (BHIVA) COVID-19 Registry
The potential impact of HIV on the outcome of COVID-19 infection is unknown, with published reports documenting inconsistent findings.
If there is an increased risk, it is unclear whether this is due to infection with HIV itself (or the immunosuppression that results), the treatment for HIV (some ART drugs have been implicated) and/or confounding factors, including demographic factors (the HIV epidemic in the UK is relatively young but disproportionately affects those of BAME background), obesity, comorbidities or socio-economic status.
In October 2020, the British HIV Association (BHIVA) established the BHIVA COVID-19 Registry which collects detailed information about people with HIV attending HIV services in the UK who are known to have acquired COVID-19.
The primary aim of the Registry is to provide a database that can be used to describe the outcomes of COVID-19 in this population and the impact of markers of HIV infection on these outcomes.
To date, information has been submitted on just under 1000 people with HIV and COVID-19; findings from the study will be presented at the national BHIVA meeting in Spring 2021 and will support national guidelines and recommendations for the management of people with HIV during the pandemic, particularly regarding advice for shielding and recommendations for service delivery.
This project is being run by the NIHR Health Protection Research Unit (HPRU) in Blood-Borne and Sexually Transmitted Infections at UCL.
Links to other research
Other research from the UCL Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), the UCL Centre for Population Research in Sexual Health and HIV, the UCL Centre for Clinical Research in Infection and Sexual Health and the UCL Centre for Molecular Epidemiology and Translational Research
Other research from IGH in the UK